alexion pharmaceuticals inc
(ALXN:Consolidated Issue Listed on NASDAQ Global Select )
Frank J. Wright
Senior Vice President and President of Alexion Pharma International Sàrl, Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Frank J. Wright serves as Senior Vice President and President of Alexion Pharma International Sàrl at Alexion Pharmaceuticals, Inc. since January 2013. Mr. Wright is responsible for leading Alexion's rapidly expanding non-US global operations from Lausanne, Switzerland. Mr. Wright has more than 40 years of increasing management experience and leadership in multinational pharmaceutical companies in the UK, South Africa and the US. Prior to joining Alexion, he worked ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*There is no Board Members Memberships data available.
University of Strathclyde
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Stephen Edward Foots||Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee|
Croda International plc
|Heinz-Jurgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer and Labour Director|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee|
Dr. Reddy's Laboratories Ltd.
|6.3M||Compensation as of Fiscal Year 2014.|